Search Results for "Diabetes"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Diabetes. Results 191 to 200 of 381 total matches.
In Brief: Oral Phenylephrine for Nasal Congestion
The Medical Letter on Drugs and Therapeutics • Dec 21, 2015 (Issue 1484)
be used cautiously in patients with cardiovascular
disease, hypertension, diabetes, hyperthyroidism ...
In 2007, an FDA advisory committee asked that placebo-controlled, dose-ranging trials be conducted to establish the efficacy of the oral decongestant phenylephrine (Sudafed PE, and others), which is sold over the counter (OTC) as a single agent and in combination with other drugs for treatment of cold and allergy symptoms. Phenylephrine replaced pseudoephedrine (Sudafed, and others) in many OTC formulations when access to pseudoephedrine-containing products was restricted in an effort to reduce their use in the synthesis of methamphetamine.CLINICAL STUDIES — In a randomized, open-label,...
In Brief: Hypertension with Erenumab (Aimovig)
The Medical Letter on Drugs and Therapeutics • Apr 05, 2021 (Issue 1621)
, dyslipidemia, and diabetes. The
median reported increases in systolic and diastolic
blood pressure were 39 ...
The once-monthly, subcutaneously injected calcitonin
gene-related peptide (CGRP) receptor antagonist
erenumab-aooe (Aimovig) was approved by the FDA
in 2018 for preventive treatment of migraine in adults.
Now the FDA has added a new warning to its labeling
about a risk of new-onset hypertension and worsening
of preexisting hypertension associated with use of the
drug. CGRP is a potent microvascular vasodilator;
blocking or deleting it has produced hypertensive
effects in animals.
Fluoxetine (Prozac) and Other Drugs for Treatment of Obesity
The Medical Letter on Drugs and Therapeutics • Nov 25, 1994 (Issue 936)
obese
patients with non-insulin-dependent diabetes following a 1200-calorie diet found that patients ...
Recent reports have suggested that some obese patients may benefit from long-term pharmacologic treatment (RL Atkinson and VS Hubbard, Am J Clin Nutr, 60:153, August 1994; DJ Goldstein and JH Potvin, Am J Clin Nutr, 60:647, November 1994). Fluoxetine (Prozac), widely used for treatment of depression and near approval by the US Food and Drug Administration (FDA) for treatment of bulimia, is also being tried for treatment of obesity.
Tadalafil (Cialis) for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Dec 22, 2003 (Issue 1172)
, double-blind trial in 216 men with erectile dysfunction associated with type
1 or 2 diabetes found ...
Tadalafil (Cialis - Lilly Icos) is the third oral drug to be approved by the FDA for treatment of erectile dysfunction. It has a longer duration of action than sildenafil (Viagra) or vardenafil (Levitra - Medical Letter 2003; 45:77).
Antibacterial Drugs for Community-Acquired Pneumonia
The Medical Letter on Drugs and Therapeutics • Jan 25, 2021 (Issue 1616)
,
diabetes, alcoholism, malignancy, or asplenia), current
guidelines recommend oral treatment with high-dose ...
Treatment of community-acquired pneumonia (CAP)
is usually empiric, with selected antibiotic regimens
directed against some of the most common causative
pathogens. Recommended empiric regimens are
listed in Table 2; recommended antibiotic dosages for
treatment of CAP are listed in Tables 3 and 4. Joint
guidelines for treatment of CAP by the American
Thoracic Society and the Infectious Diseases Society of
America (ATS/IDSA) were updated in 2019.
Initial Therapy of Hypertension
The Medical Letter on Drugs and Therapeutics • Jul 05, 2004 (Issue 1186)
infarction, stroke or diabetes. Those with known heart failure were
excluded. The mean age was 67 years ...
The importance of adequate control of hypertension in preventing organ damage and death is well established, but the choice of drugs is still controversial. Three recent drug trials, one supporting initial therapy with a diuretic, the second favoring an angiotensin converting enzyme (ACE) inhibitor, and the third showing equivalence between a calcium-channel blocker and an angiotensin-receptor blocker (ARB) have intensified the debate.
In Brief: Phentermine (Lomaira) for Weight Loss
The Medical Letter on Drugs and Therapeutics • Dec 05, 2016 (Issue 1509)
such
as hypertension, dyslipidemia, or diabetes. Phentermine
has been available alone and in combination ...
The FDA has approved Lomaira (KVK Tech), an 8-mg tablet formulation of phentermine that can be taken up to three times daily before meals, as an adjunct to lifestyle modifications for weight loss. It is only approved for short-term use (a few weeks) in adults with a body mass index (BMI) ≥30 kg/m2, or with a BMI ≥27 kg/m2 in addition to a weight-related comorbidity such as hypertension, dyslipidemia, or diabetes. Phentermine has been available alone and in combination with topiramate for years.1Lomaira was approved by the FDA under an abbreviated new drug application (ANDA) and is...
Olmesartan (Benicar) for hypertension
The Medical Letter on Drugs and Therapeutics • Aug 05, 2002 (Issue 1136)
to type 1 diabetes have
demonstrated both survival benefits and slowing of disease progression. Similar ...
Olmesartan medoxomil (Benicar - Sankyo), a substituted imidazole, is the seventh oral angiotensin II receptor blocker (ARB) approved by the FDA for treatment of hypertension.
Duloxetine (Cymbalta) for Fibromyalgia
The Medical Letter on Drugs and Therapeutics • Jul 28, 2008 (Issue 1291)
and norepinephrine
reuptake inhibitor (SNRI) that is already marketed for
treatment of depression and diabetic ...
Duloxetine (Cymbalta - Lilly) is the second drug to be approved by the FDA for treatment of fibromyalgia. Pregabalin (Lyrica), which is also approved for treatment of neuropathic pain and epilepsy, was the first. Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) that is already marketed for treatment of depression and diabetic neuropathy.
CRP and Statins for Primary Prevention of Coronary Artery Disease
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008 (Issue 1301)
. Diabetes was diagnosed during the trial in 270 patients (3%) taking rosuvastatin versus 216 patients (2.4 ...
Modestly elevated C-reactive protein (CRP) concentrations have been associated with an increased risk of coronary heart disease. The recently published and heavily publicized results of the JUPITER trial will lead many patients to ask health care professionals whether they should have a CRP test to see if they should be taking a statin.